Metabolomic analysis of biochemical changes in the plasma of high-fat diet and streptozotocin-induced diabetic rats after treatment with isoflavones extract of radix puerariae

Evidence-based Complementary and Alternative Medicine

Volumn 2016, Issue , 2016, Pages

  Zhang, Yan ^a   Wang, Ping ^a   Xu, Youdong ^a   Meng, Xianli ^a   Zhang, Yi ^a  

^a CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ARGININE; GLUTAMIC ACID; ISOFLAVONE DERIVATIVE; PLANT EXTRACT; RADIX PUERARIAE EXTRACT; RADIX PUERARIAE ISOFLAVONE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID DIET; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; METABOLIC DISORDER; METABOLOMICS; NONHUMAN; OXIDATIVE STRESS; PARTIAL LEAST SQUARES REGRESSION; PATTERN RECOGNITION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RADIX PUERARIAE; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84962300935     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2016/4701890     Document Type: Article

References (51)

1. Z. Wang, J. Wang, and P. Chan, "Treating type 2 diabetes mellitus with traditional Chinese and Indian medicinal herbs, " Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 343594, 17 pages, 2013.
2. M. L. McCullough, J. J. Peterson, R. Patel, P. F. Jacques, R. Shah, and J. T. Dwyer, "Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults, " The American Journal of Clinical Nutrition, vol. 95, no. 2, pp. 454-464, 2012.
3. P. V. A. Babu, D. Liu, and E. R. Gilbert, "Recent advances in understanding the anti-diabetic actions of dietary flavonoids, " Journal of Nutritional Biochemistry, vol. 24, no. 11, pp. 1777-1789, 2013.
4. L. Ji, X. Tong, H. Wang, et al., "Efficacy and safety of traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial, " PLoSONE, vol. 8, no. 2, Article IDe56703, 2013.
5. T. R. Chen, L. A. Chen, and Q. K. Wei, "Evaluation of quality of Radix Puerariae herbal medicine by isoflavonoids, " Journal of Pharmacy and Pharmacology, vol. 62, no. 5, pp. 644-650, 2010.
6. L. Bebrevska, K. Foubert, N. Hermans, et al., "In vivo antioxidative activity of a quantified Pueraria lobata root extract, " Journal of Ethnopharmacology, vol. 127, no. 1, pp. 112-117, 2010.
7. F.-L. Xiong, X.-H. Sun, L. Gan, X.-L. Yang, and H.-B. Xu, "Puerarin protects rat pancreatic islets from damage by hydrogen peroxide, " European Journal of Pharmacology, vol. 529, no. 1-3, pp. 1-7, 2006.
8. J. K. Prasain, N. Peng, R. Rajbhandari, and J. M. Wyss, "The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice, " Phytomedicine, vol. 20, no. 1, pp. 17-23, 2012.
9. X. Wang, H. Sun, A. Zhang, W. Sun, P. Wang, and Z. Wang, "Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese andWestern medicine, " Journal of Pharmaceutical and Biomedical Analysis, vol. 55, no. 5, pp. 859-868, 2011.
10. T. Wu, G. Xie, Y. Ni, et al., "Serummetabolite signatures of type 2 diabetes mellitus complications, " Journal of Proteome Research, vol. 14, no. 1, pp. 447-456, 2015.
11. J. Liu, C. Wang, F. Liu, Y. Lu, and J. Cheng, "Metabonomics revealed xanthine oxidase-induced oxidative stress and inflammation in the pathogenesis of diabetic nephropathy, " Analytical and Bioanalytical Chemistry, vol. 407, no. 9, pp. 2569-2579, 2015.
12. Y. Zhu, W. Cong, L. Shen, et al., "Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS), "Molecular BioSystems, vol. 10, no. 2, pp. 304-312, 2014.
13. J. Niu, Z.-F. Pi, H. Yue, et al., "Effect of 20(S)-ginsenoside Rg3 on streptozotocin-induced experimental type 2 diabetic rats: a urinary metabonomics study by rapid-resolution liquid chromatography/mass spectrometry, " Rapid Communications in Mass Spectrometry, vol. 26, no. 23, pp. 2683-2689, 2012.
14. Y. Gu, Y. Zhang, X. Shi, et al., "Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics, " Talanta, vol. 81, no. 3, pp. 766-772, 2010.
15. T. J. Wang, M. G. Larson, R. S. Vasan, et al., "Metabolite profiles and the risk of developing diabetes, " Nature Medicine, vol. 17, no. 4, pp. 448-453, 2011.
16. M. Magnusson, G. D. Lewis, U. Ericson, et al., "A diabetespredictive amino acid score and future cardiovascular disease, " European Heart Journal, vol. 34, no. 26, pp. 1982-1989, 2013.
17. I. N. Mohamed, S. A. Soliman, A. Alhusban, et al., "Diabetes exacerbates retinal oxidative stress, inflammation, and microvascular degeneration in spontaneously hypertensive rats, " Molecular Vision, vol. 18, pp. 1457-1466, 2012.
18. R. A. Floyd, "Antioxidants, oxidative stress, and degenerative neurological disorders, " Proceedings of the Society for Experimental Biology and Medicine, vol. 222, no. 3, pp. 236-245, 1999.
19. F. Giacco and M. Brownlee, "Oxidative stress and diabetic complications, " Circulation Research, vol. 107, no. 9, pp. 1058-1070, 2010.
20. A. M. Joussen, V. Poulaki, M. L. Le, et al., "A central role for inflammation in the pathogenesis of diabetic retinopathy, " The FASEB Journal, vol. 18, no. 12, pp. 1450-1452, 2004.
21. M. D. Williams and J. L. Nadler, "Inflammatory mechanisms of diabetic complications, " Current Diabetes Reports, vol. 7, no. 3, pp. 242-248, 2007.
22. F. Araujo Sampaio, M. Monte Feitosa, C. Hermes Sales, et al., "Influence of magnesium on biochemical parameters of iron and oxidative stress in patients with type 2 diabetes, " Nutricion Hospitalaria, vol. 30, no. 3, pp. 570-576, 2014.
23. H. P. C. Artese, A. M. Foz, M. de Sousa Rabelo, et al., "Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis, " PLoS ONE, vol. 10, no. 5, Article ID e0128344, 2015.
24. N. Li, Q. Liu, X. J. Li, et al., "TCM Formula Xiaoyaosan Decoction improves depressive-like behaviors in rats with type 2 diabetes, " Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 415243, 10 pages, 2015.
25. Y. Lu, Y. Liu, H. Li, X. Wang, W. Wu, and L. Gao, "Effect and mechanisms of zinc supplementation in protecting against diabetic cardiomyopathy in a rat model of type 2 diabetes, " Bosnian Journal of Basic Medical Sciences, vol. 15, no. 1, pp. 14-20, 2015.
26. V. Brzovic-Saric, I. Landeka, B. Saric, et al., "Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients, " Molecular Vision, vol. 21, pp. 649-664, 2015.
27. R. Medzhitov and T. Horng, "Transcriptional control of the inflammatory response, "Nature Reviews Immunology, vol. 9, no. 10, pp. 692-703, 2009.
28. D. Okin and R. Medzhitov, "Evolution of inflammatory diseases, " Current Biology, vol. 22, no. 17, pp. R733-R740, 2012.
29. N. Esser, S. Legrand-Poels, J. Piette, A. J. Scheen, and N. Paquot, "Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes, "Diabetes Research and Clinical Practice, vol. 105, no. 2, pp. 141-150, 2014.
30. M. Bluher, R. Unger, F. Rassoul, V. Richter, and R. Paschke, "Relation between glycaemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes, " Diabetologia, vol. 45, no. 2, pp. 210-216, 2002.
31. M. S. Ellulu, A. Rahmat, P. Ismail, H. Khazaai, and Y. Abed, "Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial, "DrugDesign, Development andTherapy, vol. 9, pp. 3405-3412, 2015.
32. J.-F. Wang, Y.-X. Guo, J.-Z. Niu, J. Liu, L.-Q. Wang, and P.-H. Li, "Effects of Radix Puerariae flavones on liver lipidmetabolism in ovariectomized rats, "World Journal of Gastroenterology, vol. 10, no. 13, pp. 1967-1970, 2004.
33. O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay, "Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW264. 7 cells, " Journal of Nutrition, vol. 133, no. 5, pp. 1238-1243, 2003.
34. N. Mishra and N. Singh, "Blood viscosity, lipid profile, and lipid peroxidation in type-1 diabetic patients with good and poor glycemic control, " North American Journal of Medical Sciences, vol. 5, no. 9, pp. 562-566, 2013.
35. N. Vazzana, P. Ranalli, C. Cuccurullo, and G. Davi, "Diabetes mellitus and thrombosis, " Thrombosis Research, vol. 129, no. 3, pp. 371-377, 2012.
36. J. K. W. Chesnutt and H.-C. Han, "Platelet size and density affect shear-induced thrombus formation in tortuous arterioles, " Physical Biology, vol. 10, no. 5, Article ID056003, 2013.
37. Z. J. Zou, Z. H. Liu, M. J. Gong, B. Han, S. M. Wang, and S. W. Liang, "Intervention effects of puerarin on blood stasis in rats revealed by a 1H NMR-based metabonomic approach, " Phytomedicine, vol. 22, no. 3, pp. 333-343, 2015.
38. H.-P. Pan, J.-Z. Yang, L.-L. Li, F. Yi, Z.-Q. Huang, and K.-W. Huang, "Experimental study of puerarin injection on the hemorheology in acute blood-stasis model rats, " Zhongguo Zhong Yao Za Zhi, vol. 28, no. 12, pp. 1178-1180, 2003.
39. K. S. Nair and K. R. Short, "Hormonal and signaling role of branched-chain amino acids, " Journal of Nutrition, vol. 135, supplement 6, pp. 1547S-1552S, 2005.
40. M. A. Avila, E. R. Garcia-Trevijano, S. C. Lu, F. J. Corrales, and J. M. Mato, "Methylthioadenosine, " International Journal of Biochemistry & Cell Biology, vol. 36, no. 11, pp. 2125-2130, 2004.
41. G. C. Mills and J. S. Mills, "Urinary excretion of methylthioadenosine in immunodeficient children, " Clinica Chimica Acta, vol. 147, no. 1, pp. 15-23, 1985.
42. C. B. Newgard, J. An, J. R. Bain, et al., "A branched-chain amino acid-relatedmetabolic signature that differentiates obese and lean humans and contributes to insulin resistance, " Cell Metabolism, vol. 9, no. 4, pp. 311-326, 2009.
43. A. K. Saha, X. J. Xu, E. Lawsonet al., "Downregulationof AMPK accompanies leucine-and glucose-induced increases in protein synthesis and insulin resistance in rat skeletalmuscle, " Diabetes, vol. 59, no. 10, pp. 2426-2434, 2010.
44. G. Bajotto, T. Murakami, M. Nagasaki, Y. Sato, and Y. Shimomura, "Decreased enzyme activity and contents of hepatic branched-chain-keto acid dehydrogenase complex subunits in a rat model for type 2 diabetesmellitus, "Metabolism: Clinical and Experimental, vol. 58, no. 10, pp. 1489-1495, 2009.
45. I. R. Lanza, S. Zhang, L. E. Ward, H. Karakelides, D. Raftery, and K. Sreekumaran Nair, "Quantitative metabolomics by 1HNMR and LC-MS/MS confirms altered metabolic pathways in diabetes, " PLoS ONE, vol. 5, no. 5, Article ID e10538, 2010.
46. J. K. Prasain, N. Peng, R. Rajbhandari, and J. Michael Wyss, "The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice, " Phytomedicine, vol. 20, no. 1, pp. 17-23, 2012.
47. Z. Fu, W. Zhang, W. Zhen, et al., "Genistein induces pancreatic-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice, " Endocrinology, vol. 151, no. 7, pp. 3026-3037, 2010.
48. A. Kelly and C. A. Stanley, "Disorders of glutamatemetabolism, " Mental Retardation and Developmental Disabilities Research Reviews, vol. 7, no. 4, pp. 287-295, 2001.
49. S. Cheng, E. P. Rhee, M. G. Larson, et al., "Metabolite profiling identifies pathways associated with metabolic risk in humans, " Circulation, vol. 125, no. 18, pp. 2222-2231, 2012.
50. M. Hidiroglou and D. M. Veira, "Plasma amino acid levels in the fat cow syndrome, " Annales de Recherches Veterinaires, vol. 13, no. 1, pp. 111-115, 1982.
51. P. Tessari, A. Coracina, L. Puricelli, et al., "Acute effect of insulin on nitric oxide synthesis in humans: a precursorproduct isotopic study, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 293, no. 3, pp. E776-E782, 2007.